Tackling London's lab space shortage
As demand for ready-available lab space is on the rise in London, we're working with our partners to increase capacity across the borough.
Mitsui Fudosan are building over
of new lab-enabled space in White City
Yoo Capital are building
of lab space in the revitalised Shepherds Bush Market area
ARC West London are building
of lab enabled space along the riverside in Hammersmith
Stanhope are retrofitting
of office space into laboratories in White City
Working with major developers
White City is becoming an important hub for the UK life sciences sector. At Novartis, we are pleased to be right in the heart of this thriving health ecosystem.
It gives us the exciting opportunity to work in closer collaboration with nearby key partners, including Imperial College London. Such partnerships are enabling greater innovation and helping us deliver on our purpose to reimagine medicine to improve and extend patients’ lives.
Chinmay Bhatt, Managing Director of Novartis UK, Ireland & Nordics and Country President UK
The opportunities for collaboration, scaling businesses and access to world-class resources, are just some of the reasons why we are home to over 150 life sciences companies.
- Autolus
- Avacta
- Axitan
- InvoX
- Lift Biosciences
- MinA Therapeutics
- MediSieve
- Novartis
- Puraffinity
- Quell
- Sixfold Bioscience
- Synthace